Pharma Journalist -

Novartis announced that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company’s Supplemental Biologics License Application (sBLA)…
Read More...

Sanofi plans to create a major leading European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (API), which are the essential…
Read More...

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients…
Read More...

STADA AG is significantly expanding its global OTC business agreeing to acquire a portfolio of well-established local and regional consumer healthcare brands from GlaxoSmithKline (GSK)…
Read More...

SMi Reports: A Regulatory outlook of the Drug/Device Combinations (DDC) product space Injectable Drug Delivery Conference has brought in a high level of engagement and positive…
Read More...

SMi reports: There will be two half-day workshops hosted by UserWise and Abbott Diagnostics after Pre-Filled Syringes West Coast 2021 The 5th annual Pre-Filled Syringes West Coast…
Read More...

SMi Reports: Lynne Ensor, Vice President, Technical, Parexel International discussed the latest development in the field, her thoughts on the developing regulatory environment and more.…
Read More...

SMi Reports: Martin Everett, Chief Scientific Officer, Antabio, who will be speaking at Superbugs & Superdrugs, discussed how the AMR market has matured over the last year, what…
Read More...

Harbour BioMed (HBM) announced completion of a Phase 1 study of HBM9161, a fully human anti-FcRn monoclonal antibody, to evaluate its safety, tolerability, pharmacokinetics and…
Read More...

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, announced it has entered…
Read More...